Skip to content

Total at other companies

Tango Therapeutics logo
Tango TherapeuticsTNGX
$222.13M+40.5%
Radian Group logo
Radian GroupRDN
$6.61B+20.6%
Axos Financial logo
Axos FinancialAX
$802.2M+890%
Popular logo
PopularBPOP
$22.64B+9.9%
COA
Hemab Therapeutics Holdings, Inc. COAG
$114.11M
CNA Financial logo
CNA FinancialCNA
$1.4B-23.8%

Other financials

Income statement

See full
Revenue$675.4M+17.1%
Gross profit$228.6M+19.2%
Operating income$123.7M+9.4%
Net income$98.5M+3.8%
EPS (diluted)$0.46+9.5%

Balance sheet

See full
Cash & equivalents$164.8M-42.5%
Total debt$10.8M+123%
Total equity$2.5B+1.1%
Total assets$3.0B+7.7%

Cash flow

See full
Operating cash flow$137.1M-7.7%
CapEx$17.0M-53.6%
Free cash flow$120.0M+7.4%

Valuation

See full
Market cap$5.53B-11.1%
Enterprise value$5.37B-9.2%
P/E14.2×-1.7×
P/S2.1×-0.6×

Profitability

See full
Gross margin34.3%+1.2pp
Operating margin18.4%-0.9pp
Net margin14.8%-2.3pp
FCF margin17.7%+1.7pp

Returns & leverage

See full
Return on equity15.6%-0.5pp
Debt / equity0.0×
Current ratio2.7×-1.4×

Where this comes from

Reported directly by Gentex in its filing.

Tagged under the XBRL concept us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis.

The official record: Gentex’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Gentex's total.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Gentex's total?
Gentex (GNTX) reported total of $112.76M in Q1 2026.
How has Gentex's total changed year-over-year?
Gentex's total decreased by 28.2% year-over-year, from $157.02M to $112.76M.
What is the long-term trend for Gentex's total?
Over 4 years (2021 to 2025), Gentex's total has grown at a -13.3% compound annual growth rate (CAGR), from $195.03M to $110.11M.